BAUM CHARLES M
SEC insider (Form 3/4/5 filer). CIK 0001579824. Director at Acrivon Therapeutics, Inc. (ACRV) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in PRIINCETON, NJ.
Companies BAUM CHARLES M has filed insider reports for
- Acrivon Therapeutics, Inc. (ACRV): Director
- PMV Pharmaceuticals, Inc. (PMVP): Director
- Poseida Therapeutics, Inc. (PSTX): Director
BAUM CHARLES M
CIK: 0001579824
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 17, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares- - Jun 4, 2026PMVP
PMV Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
42K shares- - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect9.4K shares- - Jun 13, 2025ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares- - Jun 5, 2025PMVP
PMV Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
33.5K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
Tender OfferDirect78.6K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
57K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
27.4K shares- - Jan 8, 2025PSTX
Poseida Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
27.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,275 | - | - | Direct |
| Jun 4, 2026 |  PMVP PMV Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 42,000 | - | - | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 9,366 | - | $0 | Direct |
| Jun 13, 2025 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,275 | - | - | Direct |
| Jun 5, 2025 | PMVP PMV Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 33,500 | - | - | Direct |
| Jan 8, 2025 |  PSTX Poseida Therapeutics, Inc. | Tender Offer | 78,600 | - | $0 | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 57,000 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 27,350 | - | - | Direct |
| Jan 8, 2025 | PSTX Poseida Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 27,350 | - | - | Direct |
1-9 of 9 transactions